| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Articles |
Anatomy and Human Biology Group, Kings College London (S.L.D.), The Strand, London WC2R 2LS; and Department of Neurobiology, The Babraham Institute (S.M.L.), Babraham, Cambridge CB2 4AT, United Kingdom
Address all correspondence and requests for reprints to: Suzanne L. Dickson, The Department of Physiology, University of Cambridge, Downing Street, Cambridge CB2 3EG, United Kingdom. E-mail: sld20{at}cam.ac.uk
In this study we investigated the neurochemical identity of the arcuate cells activated following GH-releasing peptide-6 (GHRP-6) injection by comparing, on consecutive sections, the distribution c-fos messenger RNA (mRNA) with that of mRNAs for peptides synthesized in arcuate cells, including neuropeptide Y (NPY), GH-releasing factor (GRF), tyrosine hydroxylase, POMC, and somatostatin. Rats bearing chronically implanted jugular catheters were injected with either 50 µg GHRP-6 or vehicle. Thirty minutes later they were terminally anesthetized and perfused with fixative. Paraffin-embedded sections of 7 µm thickness were processed using in situ hybridization for either c-fos mRNA or mRNAs for the neurochemical markers. In GHRP-6-treated rats the mean (± SEM) number of cells expressing c-fos mRNA in the arcuate nucleus (23 ± 2 cells/section per rat; n = 5) was significantly higher than for vehicle-treated controls (2 ± 1 cells/section per rat; n = 5; P < 0.001, Mann-Whitney U test). Superimposed camera lucida maps indicated that, in GHRP-6-injected rats, neurochemically identifiable cells expressing c-fos mRNA also express NPY mRNA (51 ± 4%), GRF mRNA (23 ± 1%) tyrosine hydroxylase mRNA (11 ± 3%), POMC mRNA (11 ± 2%), or somatostatin mRNA (4 ± 1%). Thus, the majority of cells expressing c-fos mRNA following GHRP-6 injection are NPY and GRF-containing cells.
This article has been cited by other articles:
![]() |
A. Mano-Otagiri, T. Nemoto, A. Sekino, N. Yamauchi, Y. Shuto, H. Sugihara, S. Oikawa, and T. Shibasaki Growth Hormone-Releasing Hormone (GHRH) Neurons in the Arcuate Nucleus (Arc) of the Hypothalamus Are Decreased in Transgenic Rats Whose Expression of Ghrelin Receptor Is Attenuated: Evidence that Ghrelin Receptor Is Involved in the Up-Regulation of GHRH Expression in the Arc Endocrinology, September 1, 2006; 147(9): 4093 - 4103. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Rigamonti, S. M. Bonomo, D. Scanniffio, S. G. Cella, and E. E. Muller Orexigenic effects of a growth hormone secretagogue and nitric oxide in aged rats and dogs: correlation with the hypothalamic expression of some neuropeptidergic/receptorial effectors mediating food intake. J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2006; 61(4): 315 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. De Smet, I. Depoortere, D. Moechars, Q. Swennen, B. Moreaux, K. Cryns, J. Tack, J. Buyse, B. Coulie, and T. L. Peeters Energy Homeostasis and Gastric Emptying in Ghrelin Knockout Mice J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 431 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zizzari, H. Halem, J. Taylor, J. Z. Dong, R. Datta, M. D. Culler, J. Epelbaum, and M. T. Bluet-Pajot Endogenous Ghrelin Regulates Episodic Growth Hormone (GH) Secretion by Amplifying GH Pulse Amplitude: Evidence from Antagonism of the GH Secretagogue-R1a Receptor Endocrinology, September 1, 2005; 146(9): 3836 - 3842. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Dornonville de la Cour, A Lindqvist, E Egecioglu, Y C L Tung, V Surve, C Ohlsson, J-O Jansson, C Erlanson-Albertsson, S L Dickson, and R Hakanson Ghrelin treatment reverses the reduction in weight gain and body fat in gastrectomised mice Gut, July 1, 2005; 54(7): 907 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Farhy and J. D. Veldhuis Deterministic construct of amplifying actions of ghrelin on pulsatile growth hormone secretion Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1649 - R1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Smith Development of Growth Hormone Secretagogues Endocr. Rev., May 1, 2005; 26(3): 346 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Smith, L. Betancourt, and Y. Sun Molecular Endocrinology and Physiology of the Aging Central Nervous System Endocr. Rev., April 1, 2005; 26(2): 203 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Steiger Eating and sleeping--their relationship to ghrelin and leptin Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1031 - R1032. [Full Text] [PDF] |
||||
![]() |
B. Bodosi, J. Gardi, I. Hajdu, E. Szentirmai, F. Obal Jr., and J. M. Krueger Rhythms of ghrelin, leptin, and sleep in rats: effects of the normal diurnal cycle, restricted feeding, and sleep deprivation Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1071 - R1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nogueiras, S. Tovar, S. E. Mitchell, D. V. Rayner, Z. A. Archer, C. Dieguez, and L. M. Williams Regulation of Growth Hormone Secretagogue Receptor Gene Expression in the Arcuate Nuclei of the Rat by Leptin and Ghrelin Diabetes, October 1, 2004; 53(10): 2552 - 2558. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. van der Lely, M. Tschop, M. L. Heiman, and E. Ghigo Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin Endocr. Rev., June 1, 2004; 25(3): 426 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Anderson, S. Jeftinija, and C. G. Scanes Growth Hormone Secretion: Molecular and Cellular Mechanisms and In Vivo Approaches Experimental Biology and Medicine, April 1, 2004; 229(4): 291 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lall, N. Balthasar, D. Carmignac, C. Magoulas, A. Sesay, P. Houston, K. Mathers, and I. Robinson Physiological Studies of Transgenic Mice Overexpressing Growth Hormone (GH) Secretagogue Receptor 1A in GH-Releasing Hormone Neurons Endocrinology, April 1, 2004; 145(4): 1602 - 1611. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. INUI, A. ASAKAWA, C. Y. BOWERS, G. MANTOVANI, A. LAVIANO, M. M. MEGUID, and M. FUJIMIYA Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ FASEB J, March 1, 2004; 18(3): 439 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Thompson, J. S Davies, A. Mode, P. A. Houston, and T. Wells Pattern-Dependent Suppression of Growth Hormone (GH) Pulsatility by Ghrelin and GH-Releasing Peptide-6 in Moderately GH-Deficient Rats Endocrinology, November 1, 2003; 144(11): 4859 - 4867. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Levin, A. A. Dunn-Meynell, M. R. Ricci, and D. E. Cummings Abnormalities of leptin and ghrelin regulation in obesity-prone juvenile rats Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E949 - E957. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Zigman and J. K. Elmquist Minireview: From Anorexia to Obesity--The Yin and Yang of Body Weight Control Endocrinology, September 1, 2003; 144(9): 3749 - 3756. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Csaba, A. Simon, L. Helboe, J. Epelbaum, and P. Dournaud Targeting sst2A Receptor-Expressing Cells in the Rat Hypothalamus through in Vivo Agonist Stimulation: Neuroanatomical Evidence for a Major Role of this Subtype in Mediating Somatostatin Functions Endocrinology, April 1, 2003; 144(4): 1564 - 1573. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Cummings and M. H. Shannon Roles for Ghrelin in the Regulation of Appetite and Body Weight Arch Surg, April 1, 2003; 138(4): 389 - 396. [Full Text] [PDF] |
||||
![]() |
G. S. Tannenbaum, J. Epelbaum, and C. Y. Bowers Interrelationship between the Novel Peptide Ghrelin and Somatostatin/Growth Hormone-Releasing Hormone in Regulation of Pulsatile Growth Hormone Secretion Endocrinology, March 1, 2003; 144(3): 967 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Obal Jr., J. Alt, P. Taishi, J. Gardi, and J. M. Krueger Sleep in mice with nonfunctional growth hormone-releasing hormone receptors Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R131 - R139. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Hewson, L. Y.C. Tung, D. W. Connell, L. Tookman, and S. L. Dickson The Rat Arcuate Nucleus Integrates Peripheral Signals Provided by Leptin, Insulin, and a Ghrelin Mimetic Diabetes, December 1, 2002; 51(12): 3412 - 3419. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tamura, J. Kamegai, T. Shimizu, S. Ishii, H. Sugihara, and S. Oikawa Ghrelin Stimulates GH But Not Food Intake in Arcuate Nucleus Ablated Rats Endocrinology, September 1, 2002; 143(9): 3268 - 3275. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tschop, M. A. Statnick, T. M. Suter, and M. L. Heiman GH-Releasing Peptide-2 Increases Fat Mass in Mice Lacking NPY: Indication for a Crucial Mediating Role of Hypothalamic Agouti-Related Protein Endocrinology, February 1, 2002; 143(2): 558 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Lawrence, A. C. Snape, F. M.-H. Baudoin, and S. M. Luckman Acute Central Ghrelin and GH Secretagogues Induce Feeding and Activate Brain Appetite Centers Endocrinology, January 1, 2002; 143(1): 155 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kamegai, H. Tamura, T. Shimizu, S. Ishii, H. Sugihara, and I. Wakabayashi Chronic Central Infusion of Ghrelin Increases Hypothalamic Neuropeptide Y and Agouti-Related Protein mRNA Levels and Body Weight in Rats Diabetes, November 1, 2001; 50(11): 2438 - 2443. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Wren, C. J. Small, C. R. Abbott, W. S. Dhillo, L. J. Seal, M. A. Cohen, R. L. Batterham, S. Taheri, S. A. Stanley, M. A. Ghatei, et al. Ghrelin Causes Hyperphagia and Obesity in Rats Diabetes, November 1, 2001; 50(11): 2540 - 2547. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Horvath, S. Diano, P. Sotonyi, M. Heiman, and M. Tschop Minireview: Ghrelin and the Regulation of Energy Balance--A Hypothalamic Perspective Endocrinology, October 1, 2001; 142(10): 4163 - 4169. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Cummings, J. Q. Purnell, R. S. Frayo, K. Schmidova, B. E. Wisse, and D. S. Weigle A Preprandial Rise in Plasma Ghrelin Levels Suggests a Role in Meal Initiation in Humans Diabetes, August 1, 2001; 50(8): 1714 - 1719. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shintani, Y. Ogawa, K. Ebihara, M. Aizawa-Abe, F. Miyanaga, K. Takaya, T. Hayashi, G. Inoue, K. Hosoda, M. Kojima, et al. Ghrelin, an Endogenous Growth Hormone Secretagogue, Is a Novel Orexigenic Peptide That Antagonizes Leptin Action Through the Activation of Hypothalamic Neuropeptide Y/Y1 Receptor Pathway Diabetes, February 1, 2001; 50(2): 227 - 232. [Abstract] [Full Text] |
||||
![]() |
S. Tullin, B. S. Hansen, M. Ankersen, J. Moller, K. A. von Cappelen, and L. Thim Adenosine Is an Agonist of the Growth Hormone Secretagogue Receptor Endocrinology, September 1, 2000; 141(9): 3397 - 3402. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Korbonits, G. Kaltsas, L. A. Perry, P. Putignano, A. B. Grossman, G. M. Besser, and P. J. Trainer The Growth Hormone Secretagogue Hexarelin Stimulates the Hypothalamo-Pituitary-Adrenal Axis via Arginine Vasopressin J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2489 - 2495. [Abstract] [Full Text] |
||||
![]() |
E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Giustina and J. D. Veldhuis Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human Endocr. Rev., December 1, 1998; 19(6): 717 - 797. [Abstract] [Full Text] |
||||
![]() |
E. Arvat, R. Giordano, J. Ramunni, G. Arnaldi, A. Colao, R. Deghenghi, G. Lombardi, F. Mantero, F. Camanni, and E. Ghigo Adrenocorticotropin and Cortisol Hyperresponsiveness to Hexarelin in Patients with Cushing's Disease Bearing a Pituitary Microadenoma, But Not in Those with Macroadenoma J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4207 - 4211. [Abstract] [Full Text] |
||||
![]() |
M. M. Skinner, R. Nass, B. Lopes, E. R. Laws, and M. O. Thorner Growth Hormone Secretagogue Receptor Expression in Human Pituitary Tumors J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4314 - 4320. [Abstract] [Full Text] |
||||
![]() |
D. F. Carmignac, P. A. Bennett, and I. C. A. F. Robinson Effects of Growth Hormone Secretagogues on Prolactin Release in Anesthetized Dwarf (dw/dw) Rats Endocrinology, August 1, 1998; 139(8): 3590 - 3596. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Svensson, L. Lönn, J.-O. Jansson, G. Murphy, D. Wyss, D. Krupa, K. Cerchio, W. Polvino, B. Gertz, I. Boseaus, et al. Two-Month Treatment of Obese Subjects with the Oral Growth Hormone (GH) Secretagogue MK-677 Increases GH Secretion, Fat-Free Mass, and Energy Expenditure J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 362 - 369. [Abstract] [Full Text] |
||||
![]() |
P. A. Bennett, G. B. Thomas, A. D. Howard, S. D. Feighner, L. H. T. Van der Ploeg, R. G. Smith, and I. C. A. F. Robinson Hypothalamic Growth Hormone Secretagogue-Receptor (GHS-R) Expression Is Regulated by Growth Hormone in the Rat Endocrinology, November 1, 1997; 138(11): 4552 - 4557. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Smith, L. H. T. Van der Ploeg, A. D. Howard, S. D. Feighner, K. Cheng, G. J. Hickey, M. J. Wyvratt Jr., M. H. Fisher, R. P. Nargund, and A. A. Patchett Peptidomimetic Regulation of Growth Hormone Secretion Endocr. Rev., October 1, 1997; 18(5): 621 - 645. [Abstract] [Full Text] |
||||
![]() |
H. Zheng, A. Bailey, M.-H. Jiang, K. Honda, H. Y. Chen, M. E. Trumbauer, L. H.T. Van der Ploeg, J. M. Schaeffer, G. Leng, and R. G. Smith Somatostatin Receptor Subtype 2 Knockout Mice Are Refractory to Growth Hormone-Negative Feedback on Arcuate Neurons Mol. Endocrinol., October 1, 1997; 11(11): 1709 - 1717. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |